The PICI Center at Weill Cornell Medicine performs discovery research to guide the development of new immunotherapeutic approaches that will be delivered by a diverse workforce to all populations. Recognizing the tremendous impact that immunotherapy can have in some cancers but also seeing the unmet clinical need in others, the PICI Center at WCM brings together basic scientists studying cancer cell biology with immunologists and T cell engineers to address these needs. This innovative, multi-disciplinary approach to deploying new therapies across a large, diverse catchment area is achieved through the collaboration of scientists and physician-scientists, community outreach professionals, veterinary oncologists and biomedical engineers. Jedd Wolchok, MD, PhD | Director Taha Merghoub, PhD | Co-Director All Investigators Related Point of View Guest Post: PICI Catalyzes Scientific Innovation Clinical Trial The AMADEUS Trial Clinical Trial The McGRAW Trial Clinical Trial The PRINCE Trial From Bench to Fireside From Metastatic Melanoma to Immune Engineering with Antoni Ribas, MD, PhD Announcement, From Bench to Fireside Dr. Elizabeth Mittendorf on breast cancer breakthroughs Announcement, From Bench to Fireside PICI’s From Bench to Fireside Podcast Returns Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research